Glutathione-rich Foods for Type 2 Diabetes

NCT04386187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-01-21

No results posted yet for this study

Summary

The purpose of this research study is to find out whether certain plant-based foods may be beneficial for individuals with type 2 diabetes. To meet the goal, study participants will be fed known amounts of foods and nutrients. Before and after participants have eaten the food, they will self-measure height, weight, and waist circumference and study staff will administer questionnaires. Blood samples will be taken at a local lab to measure blood sugar and blood lipids.All study appointments will be conducted online.

Conditions

Interventions

OTHER

GSH Foods

The intervention consists of customized foods/small meals that have been designed to be high in a single nutrient called glutathione (GSH).

OTHER

Nutrition education about glutathione sources in the diet

Four videos will outline food sources of glutathione, cooking methods to reduce systemic requirements for glutathione, food sources of nutrient cofactors for glutathione production and other related content.

OTHER

Standard of care nutrition education for type 2 diabetes

The educational control is provided with information on standard dietary interventions for diabetes as electronic handouts and web links.

Sponsors & Collaborators

Principal Investigators

  • Ryan Bradley, ND, MPH · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-28
Primary Completion
2021-04-02
Completion
2021-04-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04386187 on ClinicalTrials.gov